Idea & business scorecard

A truth-telling moment before the bet.

Describe your idea. Plumb researches the market, scores it on 17 dimensions and tells you straight: Strong Go, Conditional Go, Pivot or No-Go, plus the one thing to do next.

3 free evaluations a month · No card needed · A few minutes each

77out of 100
Strong Go

ClaimPilot

Automates insurance claim denials appeals for small dental practices, recovering revenue they currently write off.

Confidence95/100 · High

The one thing

Sign the regional dental association partnership (or two alternates) with a concrete intro mechanic, and measure CAC and conversion on the first 50 member-sourced leads

Strong Go

70+ and built to scale. Invest your time and money.

Conditional Go

50–69. Promising: check the weak spots first.

Pivot Recommended

35–49. Something is here, but not in this shape.

No-Go

Below 35. Ten minutes that save you years.

A real verdict

Everything uncertain, made visible.

A genuine Plumb evaluation of a sample B2B business, exactly as the model scored it. This is the screen every founder gets.

Worth doing? (viability)

Worth doing? (viability) score 77 out of 100

Can it grow? (scalability) 88 ±2

Strong GoResearched on the web

Worth pursuing. The fundamentals support investing time and money.

This is one of the stronger submissions I've seen at this stage: a cash-flow painkiller with a domain-expert founder, 11 paying practices, $9.8k MRR, zero churn, referral-driven growth and roughly one-month CAC payback — all bootstrapped and profitable. The problem is independently corroborated by a large volume of industry appeal guides and denial-reduction vendor content. The two honest weaknesses are competitive naivety — Overjet, Ember AI, Lassie.ai and PatientXpress already market AI denial tools to dental practices, which the founder's competitor list omits — and a growth plan resting on an unsigned association partnership executed by a two-person team with a known sales gap. The next six months should be spent proving that the per-insurer appeal dataset actually produces higher win rates than competitors and that one channel scales beyond founder-led study-club talks.

Confidence

95/100 · High

  • 8 of 10 scores backed by validated evidence
  • 21 of 21 detail questions answered
  • Checked against web research

How much to trust this report. Real evidence and fuller answers raise it.

The one thing

Sign the regional dental association partnership (or two alternates) with a concrete intro mechanic, and measure CAC and conversion on the first 50 member-sourced leads

Do this first, then re-evaluate.

Red flags

The three things most likely to kill this business.

  1. 1Materially more direct competition than the founder acknowledges: at least four vendors already sell AI denial/appeal tools into dental practices [S1, S3, S4, S5]
  2. 2First-100-customer plan depends on an unsigned association partnership and founder-led study clubs, with a self-identified sales gap on a two-person team
  3. 3Distribution and product both sit on third-party PMS API access that vendors could restrict or replicate natively, plus HIPAA exposure with no named compliance owner

The shape of the idea

All 17 dimensions on one chart. Further out is stronger.

ProblemCustomerWhy youMarketPullExecutionModelDistributionMoatTeamPainRevenueAutomationToolsRepeatableWill payLow risk
10 fundamentals7 signs it can grow (scalability)
  • Pain Intensity

    5/5

    30–60 denials a month at 45 minutes each, costing $40k–$80k in written-off revenue annually, is urgent, recurring and directly financial.

  • Revenue Impact

    5/5

    The product literally recovers cash the practice would otherwise lose, and ARPU of ~$890/month is meaningful per account.

  • Manual Labor · lower is better

    2/5

    2-hour onboarding and human review of ~10% of appeals is modest overhead on an otherwise automated workflow.

  • Tool Access

    4/5

    LLM APIs and fax/portal services are readily available; the constraint is PMS read access, where they have 3 of the top 5 but no guaranteed partner status.

  • Repeatability

    5/5

    Identical workflow across practices with per-insurer templates reused across the whole customer base.

  • Willingness to Pay

    5/5

    Practices already pay outsourced billers 7–9% of all collections, a benchmark confirmed by multiple 2026 pricing guides [S9, S11, S12], and 11 practices are already paying ClaimPilot.

  • Risk Level · lower is better

    3/5

    HIPAA obligations, dependence on third-party PMS APIs and insurer process changes are real but manageable risks for a bootstrapped, revenue-generating business.

10-point evaluation

Every criterion explained. The weakest open first.

9
Adaptability & MoatsSome proof (anecdotal)S1S3S4S5
6

The per-insurer denial-reason and winning-appeal-language dataset compounds with volume and PMS integrations create switching costs — a real if early advantage. At 11 practices the dataset is thin, and competitors like Ember AI already have Open Dental-specific appeal products, so the moat is a race rather than a lock [S3, S1].

Red flags

  • Multiple funded AI vendors already targeting the same workflow [S1, S3, S4, S5]
  • PMS vendors control the integration surface and could restrict API access or ship the feature natively

Next steps

  • →Quantify the data advantage: measure appeal win-rate improvement as a function of prior appeals seen per insurer, and show it to prospects
  • →Secure formal partner/marketplace status with at least one top-5 PMS vendor to reduce API dependency risk
4
Market Sizing & TimingProven (validated)S1S3S4S15
7

~80k independent practices is a real but not enormous SAM; at ~$890 ARPU/month that is a few hundred million dollars of theoretical ARR, adequate for a bootstrapped company. The why-now is credible: LLMs make letter drafting viable and a 2024 payer report confirms rising denial rates [S15], though the founder's attribution to specific dental policy changes is unverified.

Red flags

  • The same LLM tailwind that enables ClaimPilot is enabling well-funded competitors simultaneously [S1, S3, S4]
  • Target of 1,000 practices in 3 years implies ~1.25% SAM penetration — reachable, but requires a channel engine that isn't proven yet

Next steps

  • →Size the recoverable-dollars-per-practice-per-year by state to justify TX/FL sequencing and identify the next two states
  • →Track insurer-level denial policy changes quarterly to confirm the tailwind persists rather than reverses
6
Execution Speed & FocusProven (validated)
9

Scope is ruthlessly narrow: one segment, one workflow, two states, one primary channel, and a single obvious metric (dollars recovered). The team shipped integrations with 3 of the top 5 PMS vendors and got to revenue while bootstrapped, which is strong evidence of shipping speed.

Red flags

  • Backlog clearing at onboarding may inflate early recovery numbers and mask slower steady-state throughput

Next steps

  • →Define and publish one north-star metric (recovered dollars per practice per month) and report it weekly internally
  • →Cut onboarding from 2 hours to under 45 minutes with a templated PMS connection flow before scaling past 50 accounts

Plus the other seven in every report.

From judge to coach

Watch your score climb as you do the real work.

Talk to customers, test a channel, sign the first payer, then re-evaluate. Plumb keeps every version, so you can see exactly what moved the needle.

Score history

Illustrative example

41 → 78 (+37)

Strong Go 70Conditional 50Pivot 35Version 1 · 41 · Pivot Recommended41Version 2 · 58 · Conditional Go58Version 3 · 78 · Strong Go78
  1. v1 · 41 · Pivot
  2. v2 · 58 · Conditional
  3. v3 · 78 · Go

How it works

Describe. Research. Verdict.

  1. 01

    Describe it

    Who it serves, the problem, how it makes money. Add the evidence you have: conversations, traction, economics.

  2. 02

    It's researched and scored

    Plumb checks your claims against the live web, then scores 17 dimensions on a published rubric. Unproven claims are discounted.

  3. 03

    Get the verdict

    A score out of 100, one of four verdicts, the red flags, the one thing to do next, and how far to trust it all.

The method, in the open

No black box. Every weight is published.

The AI scores each point against written descriptions; a fixed formula does the math. The same judgments always produce the same verdict.

Read the full method →

The evidence rule

Scores are discounted by how well each claim is backed up:

assumed
×0.85
anecdotal
×0.95
validated
×1.00

Pricing

Killing a bad idea should be free.

See plans →

Free

$0 forever

3 full evaluations a month, web research on every run, the full verdict screen.

Start free

Pro

Most popular

$15 per month

30 evaluations a month. Re-evaluate as you gather evidence. Cancel anytime.

Upgrade to Pro

Know before you commit.

Ten minutes of honesty before years of your life.

Evaluate an idea free